Bedel Financial Consulting’s ResMed RMD Stock Holding History

Bedel Financial Consulting’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-1,000	Closed	-$224K	–	316
2026 Q1	$224K	Hold	1,000	–	–	0.03%	278
2025 Q4	$241K	Sell	1,000 -1,100	-52%	-$281K	0.03%	250
2025 Q3	$575K	Hold	2,100	–	–	0.07%	145
2025 Q2	$542K	Hold	2,100	–	–	0.07%	149
2025 Q1	$508K	Hold	2,100	–	–	0.07%	147
2024 Q4	$509K	Hold	2,100	–	–	0.07%	150
2024 Q3	$513K	Hold	2,100	–	–	0.07%	138
2024 Q2	$402K	Hold	2,100	–	–	0.06%	155
2024 Q1	$416K	Hold	2,100	–	–	0.07%	158
2023 Q4	$361K	Hold	2,100	–	–	0.07%	161
2023 Q3	$311K	Hold	2,100	–	–	0.06%	168
2023 Q2	$459K	Hold	2,100	–	–	0.1%	126
2023 Q1	$460K	Hold	2,100	–	–	0.11%	122
2022 Q4	$437K	Hold	2,100	–	–	0.11%	123
2022 Q3	$447K	Hold	2,100	–	–	0.12%	120
2022 Q2	$440K	Hold	2,100	–	–	0.13%	111
2022 Q1	$509K	Hold	2,100	–	–	0.16%	91
2021 Q4	$547K	Sell	2,100 -100	-5%	-$25.9K	0.17%	83
2021 Q3	$580K	Hold	2,200	–	–	0.2%	76
2021 Q2	$542K	Hold	2,200	–	–	0.19%	83
2021 Q1	$427K	Buy	+2,200	New	+$441K	0.17%	101

Other funds holding RMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bedel Financial Consulting's RMD Position: Q2 2026 in Review

Bedel Financial Consulting sold out of ResMed (RMD) in Q2 2026, closing a stake of 1,000 shares — an estimated $224K sold.

Bedel Financial Consulting first reported a position in RMD in Q1 2021 and held it in 21 quarters. The position peaked at $580K in Q3 2021. 891 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

Bedel Financial Consulting reported no remaining ResMed position as of Q2 2026 after selling out during the quarter.
Bedel Financial Consulting sold 1,000 ResMed shares in Q2 2026, an estimated $224K.
Bedel Financial Consulting first reported a position in ResMed in Q1 2021 and held it in 21 quarters.
Bedel Financial Consulting's ResMed position peaked at $580K in Q3 2021.
891 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Bedel Financial Consulting's 13F filing for Q2 2026, filed 29 Jul 2026.